Mechanical valve replacement is a primary treatment for rheumatic heart disease, yet prosthesis-related adverse outcomes remain underreported in ...

New five-year results show strong durability for transcatheter mitral valve replacement. Keep reading to learn what the data ...

Background and objectives Mechanical valve replacement is a primary treatment for rheumatic heart disease, yet ...

Testing by Rutgers Health and other institutions is reshaping how – and how gently – doctors repair failing valves.

The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve ...

A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.

Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...

PhD Defense: Improving Clinical Management of Rheumatic Heart Disease in Developing Countries: Focus on Indonesia ...

The results showed that minimally invasive surgery is superior to conventional median thoracic osteotomy in terms of safety ...

Faridabad: Doctors at Fortis Escorts Hospital, Faridabad have successfully treated a 65-year-old woman suffering from severe ...

JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve ...

Conclusion Last week, we took our readers on a journey back to the year 1628, almost 400 years ago, when blood circulation, ...